| abstract |
The present invention provides compounds of formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and R8 have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods, as well as a method and useful intermediates for the preparation of compounds of formula (I). The compounds are 5-HT ligands, and are useful for the treatment of diseases where modulation of 5-HT activity is desired. |